Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Schönenberger CM, Schobinger S, Agoritsas T, Tomashek KM, Nayak S, Makowski M, Morales-Ortega A, Bernal-Bello D, Pomponio G, Ferrarini A, Ghazaeian M, Hall F, Bond S, García-Morales MT, Jiménez-González M, Arribas JR, Guimaraães PO, Tavares CAM, Berwanger O, Yazdanpanah Y et al. (2025)
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
Lancet Respir Med, 13 (6), 530-544
DOI 10.1016/S2213-2600(25)00055-4, PubMed 40378861

Andersen T, Ueland T, Aukrust P, Nilsen DW, Grundt H, Staines H, Kontny F (2025)
Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes
Front Cardiovasc Med, 12, 1650098
DOI 10.3389/fcvm.2025.1650098, PubMed 40693227

Andersen T, Ueland T, Aukrust P, Nilsen DWT, Grundt H, Staines H, Pönitz V, Kontny F (2025)
Correction: Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
Front Cardiovasc Med, 12, 1650107
DOI 10.3389/fcvm.2025.1650107, PubMed 40693223